sulfasalazine has been researched along with Hepatitis B Virus Infection in 7 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, whether hepatitis B affects treatment outcome remains unclear." | 1.48 | Disease Characteristics and Change in Arthritis Activity according to Treatment in Hepatitis B Surface Antigen-positive Rheumatoid Arthritis Patients: a Retrospective Chart Review Study. ( Cha, HS; Choi, MS; Eun, Y; Jeong, H; Kim, H; Kim, IY; Koh, E; Lee, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, S | 1 |
| Zhen, Y | 1 |
| Fu, L | 2 |
| Gao, F | 1 |
| Zhou, X | 1 |
| Huang, S | 1 |
| Zhang, L | 2 |
| Chen, S | 1 |
| Chen, Y | 1 |
| Donkers, JM | 1 |
| Zehnder, B | 1 |
| van Westen, GJP | 1 |
| Kwakkenbos, MJ | 1 |
| IJzerman, AP | 1 |
| Oude Elferink, RPJ | 1 |
| Beuers, U | 1 |
| Urban, S | 1 |
| van de Graaf, SFJ | 1 |
| Eun, Y | 1 |
| Kim, IY | 1 |
| Jeong, H | 1 |
| Kim, H | 1 |
| Lee, J | 1 |
| Choi, MS | 1 |
| Koh, E | 1 |
| Cha, HS | 1 |
| Akashi, K | 1 |
| Saegusa, J | 1 |
| Nakamachi, Y | 1 |
| Nakazawa, T | 1 |
| Kumagai, S | 1 |
| Morinobu, A | 1 |
| Fielding, JF | 1 |
| Arthurs, Y | 1 |
| Doyle, GD | 1 |
| Hillemeier, C | 1 |
1 review available for sulfasalazine and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interf | 2022 |
6 other studies available for sulfasalazine and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Benzamides; Drug Design; Hep G2 Cells; Hepatitis | 2019 |
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.
Topics: Animals; Antiviral Agents; Dogs; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; | 2017 |
Disease Characteristics and Change in Arthritis Activity according to Treatment in Hepatitis B Surface Antigen-positive Rheumatoid Arthritis Patients: a Retrospective Chart Review Study.
Topics: Adult; Alanine Transaminase; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Rea | 2018 |
Hepatitis B Virus Reactivation Following Salazosulfapyridine Monotherapy in a Patient with Rheumatoid Arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; DNA, Viral; Hepatitis B; Hepatitis B Surface Anti | 2016 |
Sulphasalazine treatment in hepatitis B virus (HBV) associated chronic active hepatitis (CAH)--a pilot study.
Topics: Adult; Chronic Disease; Hepatitis B; Humans; Male; Pilot Projects; Sulfasalazine | 1982 |
New developments: gastroenterology.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Digestive System; Female; Gastroenterology; H | 1993 |